-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
GRL-0496
Category | SARS-CoV |
CAS | 1087243-14-8 |
Description | GRL-0496 is a potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitor, with an IC50 of 30 nM in both enzyme inhibitory and antiviral assays. GRL-0496 shows SARS-CoV antiviral activity, with an EC50 of 6.9 μM. |
Product Information
Synonyms | GRL-0496|(5-chloropyridin-3-yl) 1H-indole-4-carboxylate|CHEMBL490820|SCHEMBL22875686|GTPL11173|jm5b01461, Compound 124|ALP-POS-c59291d4-5|GRL0496|CHEBI:149970|BDBM429304|compound 10 [PMID:18796354]|1087243-14-8|HY-137954|CS-0143213|5-chloropyridin-3-yl 1H-indole-4-carboxylate |
Molecular Weight | 272.69 |
Molecular Formula | C14H9ClN2O2 |
Canonical SMILES | C1=CC(=C2C=CNC2=C1)C(=O)OC3=CC(=CN=C3)Cl |
Purity | ≥98% (HPLC) |
Solubility | In Vitro: DMSO : 100 mg/mL(366.72 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.5 mg/mL (9.17 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (9.17 mM); Clear solution 3.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.5 mg/mL (9.17 mM); Clear solution |
Appearance | Light yellow to green yellow (Solid) |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 339 |
Exact Mass | 272.0352552 |
In Vitro | GRL-0496 shows SARS-CoV antiviral activity, with an EC50 of 6.9 μM. |
Target | IC50: 30 nM (SARS-CoV 3CLpro) |
XLogP3-AA | 2.8 |